These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23779146)

  • 1. State of the art in human risk assessment of silver compounds in consumer products: a conference report on silver and nanosilver held at the BfR in 2012.
    Schäfer B; Brocke JV; Epp A; Götz M; Herzberg F; Kneuer C; Sommer Y; Tentschert J; Noll M; Günther I; Banasiak U; Böl GF; Lampen A; Luch A; Hensel A
    Arch Toxicol; 2013 Dec; 87(12):2249-62. PubMed ID: 23779146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosilver: application and novel aspects of toxicology.
    Schluesener JK; Schluesener HJ
    Arch Toxicol; 2013 Apr; 87(4):569-76. PubMed ID: 23344422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosilver in consumer products and human health: more information required!
    Schäfer B; Tentschert J; Luch A
    Environ Sci Technol; 2011 Sep; 45(17):7589-90; author reply 7593-5. PubMed ID: 21819100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nanosilver - harmful effects of biological activity].
    Świdwińska-Gajewska AM; Czerczak S
    Med Pr; 2014; 65(6):831-45. PubMed ID: 25902699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of nanosilver on human health and the environment.
    Rezvani E; Rafferty A; McGuinness C; Kennedy J
    Acta Biomater; 2019 Aug; 94():145-159. PubMed ID: 31125729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nanosilver--Occupational exposure limits].
    Świdwińska-Gajewska AM; Czerczak S
    Med Pr; 2015; 66(3):429-42. PubMed ID: 26325054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 120 years of nanosilver history: implications for policy makers.
    Nowack B; Krug HF; Height M
    Environ Sci Technol; 2011 Feb; 45(4):1177-83. PubMed ID: 21218770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The release of nanosilver from consumer products used in the home.
    Benn T; Cavanagh B; Hristovski K; Posner JD; Westerhoff P
    J Environ Qual; 2010; 39(6):1875-82. PubMed ID: 21284285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic effects of nanosilver are highly dependent on the chloride concentration and the presence of organic compounds in the cell culture media.
    Kaiser JP; Roesslein M; Diener L; Wichser A; Nowack B; Wick P
    J Nanobiotechnology; 2017 Jan; 15(1):5. PubMed ID: 28061858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of nanosilver in intragastric studies: Biodistribution and metabolic effects.
    Hendrickson OD; Klochkov SG; Novikova OV; Bravova IM; Shevtsova EF; Safenkova IV; Zherdev AV; Bachurin SO; Dzantiev BB
    Toxicol Lett; 2016 Jan; 241():184-92. PubMed ID: 26617184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecologically based methods for promoting safer nanosilver for environmental applications.
    Bellingeri A; Scattoni M; Venditti I; Battocchio C; Protano G; Corsi I
    J Hazard Mater; 2022 Sep; 438():129523. PubMed ID: 35820334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture.
    Sahu SC; Zheng J; Graham L; Chen L; Ihrie J; Yourick JJ; Sprando RL
    J Appl Toxicol; 2014 Nov; 34(11):1155-66. PubMed ID: 24522958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "120 Years of nanosilver history: implications for policy makers".
    Costanza J; El Badawy AM; Tolaymat TM
    Environ Sci Technol; 2011 Sep; 45(17):7591-2; author reply 7593-5. PubMed ID: 21819108
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a modified GreenScreen tool to conduct a screening-level comparative hazard assessment of conventional silver and two forms of nanosilver.
    Sass J; Heine L; Hwang N
    Environ Health; 2016 Nov; 15(1):105. PubMed ID: 27825359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by the cytokinesis-block micronucleus assay.
    Sahu SC; Roy S; Zheng J; Ihrie J
    J Appl Toxicol; 2016 Apr; 36(4):532-42. PubMed ID: 26813850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric evaluation of the contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cells.
    Sahu SC; Njoroge J; Bryce SM; Zheng J; Ihrie J
    J Appl Toxicol; 2016 Apr; 36(4):521-31. PubMed ID: 26732652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nanosilver and ionic silver toxicity in Daphnia magna and Pimephales promelas.
    Hoheisel SM; Diamond S; Mount D
    Environ Toxicol Chem; 2012 Nov; 31(11):2557-63. PubMed ID: 22887018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells.
    Hsin YH; Chen CF; Huang S; Shih TS; Lai PS; Chueh PJ
    Toxicol Lett; 2008 Jul; 179(3):130-9. PubMed ID: 18547751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver products for medical indications: risk-benefit assessment.
    Fung MC; Bowen DL
    J Toxicol Clin Toxicol; 1996; 34(1):119-26. PubMed ID: 8632503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological effects and possible modes of action of nanosilver.
    Völker C; Oetken M; Oehlmann J
    Rev Environ Contam Toxicol; 2013; 223():81-106. PubMed ID: 23149813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.